Cargando…

Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?

Since the 1980 s, when cell transplantation into the brain as a cure for Parkinson's disease hit the headlines, several patients with Parkinson's disease have received transplantation of cells from aborted fetuses with the aim of replacing the dopamine cells destroyed by the disease. The r...

Descripción completa

Detalles Bibliográficos
Autor principal:	Politis, Marios
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003184/ https://www.ncbi.nlm.nih.gov/pubmed/21126348 http://dx.doi.org/10.1186/1741-7015-8-80

Ejemplares similares

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Ocular surface inflammation in dry eye disease: What we know and what we do not
por: Vazirani, Jayesh
Publicado: (2018)

Tight glycemic control: what do we really know, and what should we expect?
por: Nasraway, Stanley A, et al.
Publicado: (2010)

Commentary: Is this a case in which we know what we don't know what we don't know?
por: Nantsios, Alex, et al.
Publicado: (2021)

Colonization and infection of the respiratory tract: What do we know?
por: Robinson, Joan
Publicado: (2004)

Maintenance of physical activity: Do we know what we are talking about?
por: Kahlert, Daniela
Publicado: (2015)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

COVID-19 in Children: What We Know and What We Don’t Know?
por: Jat, Kana Ram
Publicado: (2021)

Breast cancer risk perception: what do we know and understand?
por: Hopwood, Penelope
Publicado: (2000)

The postictal state — What do we know?
por: Pottkämper, Julia C. M., et al.
Publicado: (2020)

Cardiac amyloidosis and surgery: What do we know about rare diseases?
por: Mestres, Carlos A., et al.
Publicado: (2021)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Pregnant adolescents living with HIV: what we know, what we need to know, where we need to go
por: Callahan, Tegan, et al.
Publicado: (2017)

Commentary: When we don't know what we don't know
por: Paone, Gaetano
Publicado: (2020)

Trastuzumab-related cardiotoxicity: what do we know in 2020?
por: Liu, Jia, et al.
Publicado: (2020)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Commentary: Extracorporeal membrane oxygenation for patients with refractory Coronavirus Disease 2019 (COVID-19): What do we know and what do we need to learn?
por: Jacobs, Jeffrey P., et al.
Publicado: (2022)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Doing What We Know, Knowing What to Do: Californians Linking Action with Science for Prevention of Breast Cancer (CLASP-BC)
por: Kerner, Jon F., et al.
Publicado: (2020)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

What we know and what we don't know about cancer risks associated with radiation doses from radiological imaging
por: Brenner, D J
Publicado: (2014)

Adolescent pregnancy, nutrition, and health outcomes in low‐ and middle‐income countries: what we know and what we don't know
por: Johnson, W, et al.
Publicado: (2015)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Ultra-processed foods and human health: What do we already know and what will further research tell us?
por: Srour, Bernard, et al.
Publicado: (2021)

Investigating emotions in Parkinson's disease: what we know and what we still don't know
por: Sotgiu, Igor, et al.
Publicado: (2013)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Systematic Review of Childhood Sedentary Behavior Questionnaires: What do We Know and What is Next?
por: Hidding, Lisan M., et al.
Publicado: (2016)

Editorial: Sexual selection and environmental change: what do we know and what comes next?
por: Pilakouta, Natalie, et al.
Publicado: (2021)

What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?
por: Lacroix, Clémence, et al.
Publicado: (2022)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

The impact of economic crises on social inequalities in health: what do we know so far?
por: Bacigalupe, Amaia, et al.
Publicado: (2014)

Gambling disorder in adolescents: what do we know about this social problem and its consequences?
por: Ferrara, Pietro, et al.
Publicado: (2018)

Coagulation profile in severe COVID-19 patients: what do we know so far?
por: Savioli, Felicio, et al.
Publicado: (2020)

Understanding the lingering consequences of what we treat and what we do
por: Angus, Derek C
Publicado: (2004)

Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
por: Politis, Marios
Publicado: (2011)

Ten myths and twenty years: What we know and what we still do not know about work addiction: Commentary on: Ten myths about work addiction (Griffiths et al., 2018)
por: Kun, Bernadette
Publicado: (2018)

What Do We Know about Theory of Mind Impairment in Parkinson’s Disease?
por: Trompeta, Clara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g1osvj2dhj2uqadb8lo48tlea7